Agilon Health (AGL) Stock Price, News & Analysis

Company Overview

Agilon Health is a U.S. healthcare company that partners with primary care physicians to provide care for patients enrolled in Medicare Advantage plans. Its model is designed to help physician groups move from traditional fee-for-service care toward value-based care, in which providers are rewarded for improving patients’ health and coordinating their care.

The company provides participating physician groups with clinical, operational, technology and administrative support, along with resources to manage patient populations and coordinate care across local healthcare networks. Physicians continue to deliver care in their communities while using agilon’s platform to support practice operations and care management.

Agilon works with physician partners in communities across the United States. Its business focuses primarily on the Medicare population and on supporting primary care practices as they take a larger role in managing patients’ overall care.

Key Stats

• Today's Range: $110.10 to $114.26
• 50-Day Range: $75.85 to $114.20
• 52-Week Range: $7.48 to $133.04
• Volume: 148,807 shs
• Average Volume: 217,706 shs
• Market Capitalization: $1.91 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $102.25
• Consensus Rating: Hold

Agilon Health Stock Analysis - MarketRank™

Agilon Health scored higher than 26% of companies evaluated by MarketBeat, and ranked 760th out of 881 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.7 / 5
• Analyst Rating: Hold

Consensus Rating

Agilon Health has received a consensus rating of Hold. The company's average rating score is 2.29, and is based on no strong buy ratings, 6 buy ratings, 6 hold ratings, and 2 sell ratings.

Downside Risk

Agilon Health has a consensus price target of $102.25, representing about 9.9% downside from its current price of $113.54.

Amount of Analyst Coverage

Agilon Health has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Agilon Health are expected to grow in the coming year, from ($2.90) to $1.20 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Agilon Health is -20.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Agilon Health is -20.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Agilon Health has a P/B Ratio of 6.79. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

5.17% of the float of Agilon Health has been sold short.

Short Interest Ratio / Days to Cover

Agilon Health has a short interest ratio ("days to cover") of 4.71.

Change versus previous month

Short interest in Agilon Health has recently decreased by 5.83%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Agilon Health does not currently pay a dividend.

Dividend Growth

Agilon Health does not have a long track record of dividend growth.

Dividend Sustainability

Based on EPS estimates, Agilon Health will have a dividend payout ratio of 150.00% in the coming year. This indicates that Agilon Health may not be able to sustain their current dividend.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 0.60

News Sentiment

Agilon Health has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 15 news articles for Agilon Health this week, compared to 7 articles on an average week.

Search Interest

3 people have searched for AGL on MarketBeat in the last 30 days.

MarketBeat Follows

Only 1 people have added Agilon Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

Company Ownership

• Score: 0.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Agilon Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

2.50% of the stock of Agilon Health is held by insiders.

Percentage Held by Institutions

Agilon Health has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 11/04/2026
• Today: 11/11/2026
• Status update: 11/17/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NYSE:AGL
• CIK: 1831097
• Web: agilonhealth.com
• Phone: 562-256-3800
• Fax: N/A
• Employees: 856
• Year Founded: 2016

Price Target and Rating

• Average Price Target for Agilon Health: $102.25
• High Price Target: $146.00
• Low Price Target: $48.00
• Potential Upside/Downside: -9.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.29
• Research Coverage: 14 Analysts

Profitability

• EPS (Trailing Twelve Months): ($5.55)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 94.62
• P/E Growth: N/A
• Net Income: -$391.35 million
• Net Margins: -1.45%
• Pretax Margin: -1.68%
• Return on Equity: -51.97%
• Return on Assets: -7.15%

Debt

• Debt-to-Equity Ratio: 0.06
• Current Ratio: 1.13
• Quick Ratio: 1.13

Sales & Book Value

• Annual Sales: $5.93 billion
• Price / Sales: 0.32
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $16.72 per share
• Price / Book: 6.79

Miscellaneous

• Outstanding Shares: 16,800,000
• Free Float: 16,376,000
• Market Cap: $1.91 billion
• Optionable: Optionable
• Beta: 3.10